Ceribell vs Kestra Medical Technologies
Ceribell and Kestra Medical Technologies are similar in size: $89.1m and $95.1m of revenue in their latest fiscal years. Kestra Medical Technologies grew faster (59.0% against 36.1%). Ceribell kept more of each dollar of sales as profit: a net margin of -60.0% against -138.4%. Ceribell carries less debt relative to equity (12.8% against 16.4%).
| Latest fiscal year | CeribellCBLL, 2025 | Kestra Medical TechnologiesKMTS, 2026 |
|---|---|---|
| Revenue | $89.1m | $95.1m |
| Revenue growth | 36.1% | 59.0% |
| Net income | −$53.4m | −$132m |
| Operating margin | -65.6% | -141.6% |
| Net margin | -60.0% | -138.4% |
| Return on equity | -30.8% | -56.6% |
| Free cash flow | −$41.6m | −$117m |
| Cash | $40.5m | $99.7m |
| Total debt | $19.8m | $42.6m |
| Debt to equity | 12.8% | 16.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 327 | 443 |
| Market value | $1.09bn | $1.74bn |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 100 sales | 1 buys, 49 sales |